Current status of early phase clinical trial in Korea.
ㆍ Anti-cancer activity of (E)-2, 4-bis (p-hydroxyphenyl)-2-butenal through inactivation of NF-κB and regulation of death receptor in human non small cell lung cancer cell lines. …..... Read More
If you have any question you can ask below or enter what you are looking for!
ㆍ Anti-cancer activity of (E)-2, 4-bis (p-hydroxyphenyl)-2-butenal through inactivation of NF-κB and regulation of death receptor in human non small cell lung cancer cell lines. …..... Read More